993 related articles for article (PubMed ID: 32365221)
1. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
[TBL] [Abstract][Full Text] [Related]
2. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
[TBL] [Abstract][Full Text] [Related]
3. IL-6-based mortality risk model for hospitalized patients with COVID-19.
Laguna-Goya R; Utrero-Rico A; Talayero P; Lasa-Lazaro M; Ramirez-Fernandez A; Naranjo L; Segura-Tudela A; Cabrera-Marante O; Rodriguez de Frias E; Garcia-Garcia R; Fernández-Ruiz M; Aguado JM; Martinez-Lopez J; Lopez EA; Catalan M; Serrano A; Paz-Artal E
J Allergy Clin Immunol; 2020 Oct; 146(4):799-807.e9. PubMed ID: 32710975
[TBL] [Abstract][Full Text] [Related]
4. Establishing a model for predicting the outcome of COVID-19 based on combination of laboratory tests.
Wang F; Hou H; Wang T; Luo Y; Tang G; Wu S; Zhou H; Sun Z
Travel Med Infect Dis; 2020; 36():101782. PubMed ID: 32526372
[TBL] [Abstract][Full Text] [Related]
5. Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019.
Huang L; Zhao X; Qi Y; Li H; Ye G; Liu Y; Zhang Y; Gou J
Cell Mol Immunol; 2020 Oct; 17(10):1092-1094. PubMed ID: 32917983
[No Abstract] [Full Text] [Related]
6. Immune characteristics distinguish patients with severe disease associated with SARS-CoV-2.
Li X; Liu Y; Li J; Sun L; Yang J; Xu F; Zhou J; Wan L; Xu X; Le A; Zhang W
Immunol Res; 2020 Dec; 68(6):398-404. PubMed ID: 32989677
[TBL] [Abstract][Full Text] [Related]
7. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
Han H; Ma Q; Li C; Liu R; Zhao L; Wang W; Zhang P; Liu X; Gao G; Liu F; Jiang Y; Cheng X; Zhu C; Xia Y
Emerg Microbes Infect; 2020 Dec; 9(1):1123-1130. PubMed ID: 32475230
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.
Sayah W; Berkane I; Guermache I; Sabri M; Lakhal FZ; Yasmine Rahali S; Djidjeli A; Lamara Mahammed L; Merah F; Belaid B; Berkani L; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Hamidi RM; Ayoub S; Raaf NB; Derrar F; Gharnaout M; Allam I; Djidjik R
Cytokine; 2021 May; 141():155428. PubMed ID: 33550165
[TBL] [Abstract][Full Text] [Related]
9. Prediction Model Based on the Combination of Cytokines and Lymphocyte Subsets for Prognosis of SARS-CoV-2 Infection.
Luo Y; Mao L; Yuan X; Xue Y; Lin Q; Tang G; Song H; Wang F; Sun Z
J Clin Immunol; 2020 Oct; 40(7):960-969. PubMed ID: 32661797
[TBL] [Abstract][Full Text] [Related]
10. The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
Akbari H; Tabrizi R; Lankarani KB; Aria H; Vakili S; Asadian F; Noroozi S; Keshavarz P; Faramarz S
Life Sci; 2020 Oct; 258():118167. PubMed ID: 32735885
[TBL] [Abstract][Full Text] [Related]
11. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early.
Tan C; Huang Y; Shi F; Tan K; Ma Q; Chen Y; Jiang X; Li X
J Med Virol; 2020 Jul; 92(7):856-862. PubMed ID: 32281668
[TBL] [Abstract][Full Text] [Related]
12. Selective CD8 cell reduction by SARS-CoV-2 is associated with a worse prognosis and systemic inflammation in COVID-19 patients.
Urra JM; Cabrera CM; Porras L; Ródenas I
Clin Immunol; 2020 Aug; 217():108486. PubMed ID: 32479985
[TBL] [Abstract][Full Text] [Related]
13. Long-term infection of SARS-CoV-2 changed the body's immune status.
Lin L; Luo S; Qin R; Yang M; Wang X; Yang Q; Zhang Y; Wang Q; Zhu R; Fan H; Wang H; Hu Y; Wang L; Hu D
Clin Immunol; 2020 Sep; 218():108524. PubMed ID: 32659373
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 and severity of COVID-19 patients in Hefei, China.
Zhao Z; Xie J; Yin M; Yang Y; Ding C; Gao Y; Ma X
Med Mal Infect; 2020 Oct; 50(7):629-631. PubMed ID: 32593746
[TBL] [Abstract][Full Text] [Related]
15. The changes of the peripheral CD4+ lymphocytes and inflammatory cytokines in Patients with COVID-19.
Sun HB; Zhang YM; Huang LG; Lai QN; Mo Q; Ye XZ; Wang T; Zhu ZZ; Lv XL; Luo YJ; Gao SD; Xu JS; Zhu HH; Li T; Wang ZK
PLoS One; 2020; 15(9):e0239532. PubMed ID: 32976531
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients.
Elshazli RM; Toraih EA; Elgaml A; El-Mowafy M; El-Mesery M; Amin MN; Hussein MH; Killackey MT; Fawzy MS; Kandil E
PLoS One; 2020; 15(8):e0238160. PubMed ID: 32822430
[TBL] [Abstract][Full Text] [Related]
17. Viral and host factors related to the clinical outcome of COVID-19.
Zhang X; Tan Y; Ling Y; Lu G; Liu F; Yi Z; Jia X; Wu M; Shi B; Xu S; Chen J; Wang W; Chen B; Jiang L; Yu S; Lu J; Wang J; Xu M; Yuan Z; Zhang Q; Zhang X; Zhao G; Wang S; Chen S; Lu H
Nature; 2020 Jul; 583(7816):437-440. PubMed ID: 32434211
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.
Liu J; Li S; Liu J; Liang B; Wang X; Wang H; Li W; Tong Q; Yi J; Zhao L; Xiong L; Guo C; Tian J; Luo J; Yao J; Pang R; Shen H; Peng C; Liu T; Zhang Q; Wu J; Xu L; Lu S; Wang B; Weng Z; Han C; Zhu H; Zhou R; Zhou H; Chen X; Ye P; Zhu B; Wang L; Zhou W; He S; He Y; Jie S; Wei P; Zhang J; Lu Y; Wang W; Zhang L; Li L; Zhou F; Wang J; Dittmer U; Lu M; Hu Y; Yang D; Zheng X
EBioMedicine; 2020 May; 55():102763. PubMed ID: 32361250
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the Inflammatory Response to Severe COVID-19 Illness.
McElvaney OJ; McEvoy NL; McElvaney OF; Carroll TP; Murphy MP; Dunlea DM; Ní Choileáin O; Clarke J; O'Connor E; Hogan G; Ryan D; Sulaiman I; Gunaratnam C; Branagan P; O'Brien ME; Morgan RK; Costello RW; Hurley K; Walsh S; de Barra E; McNally C; McConkey S; Boland F; Galvin S; Kiernan F; O'Rourke J; Dwyer R; Power M; Geoghegan P; Larkin C; O'Leary RA; Freeman J; Gaffney A; Marsh B; Curley GF; McElvaney NG
Am J Respir Crit Care Med; 2020 Sep; 202(6):812-821. PubMed ID: 32584597
[No Abstract] [Full Text] [Related]
20. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z
JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]